Insulin: the one compound here where a mistake can kill you the same afternoon

This page exists because people use insulin for physique goals and because the information they find is usually written either by someone selling a protocol or by someone who will not discuss it at all. Neither helps. What follows is what the hormone does, what the evidence for the non-medical use actually is, and what the failure mode looks like — in enough detail to make a decision with.

What insulin does

Established clinical use Insulin is a 51-amino-acid peptide hormone made by the beta cells of the pancreas. Its central job is to move things out of the bloodstream and into cells: glucose, amino acids and potassium. It switches the body from breaking fuel down to storing it — glycogen synthesis up, gluconeogenesis down, lipolysis suppressed, protein synthesis supported. It has been in clinical use since 1922 and there is no hormone in medicine that is better characterised.

Injected insulin replaces or supplements that signal. In type 1 diabetes it is not a treatment but a requirement, and in type 2 it is added when other agents stop holding the line. Products differ mainly in timing: rapid-acting analogues (lispro, aspart) begin working within about fifteen minutes and are finished in a few hours; regular human insulin is slower on both ends; long-acting analogues (glargine, degludec) are designed to sit flat across a day or more. That difference in timing is the whole safety picture, which is why this page carries no single half-life figure — the number depends entirely on which product is in the vial.

Everything else in this site’s metabolic section is, in one way or another, about this hormone. Metformin reduces hepatic glucose output and improves sensitivity to it. The GLP-1 agonists amplify the body’s own glucose-dependent insulin release. Berberine and acarbose blunt the glucose load that provokes it. Insulin is the only one that bypasses the regulation entirely, and that is exactly what makes it different.

Why it appears in bodybuilding, and what the evidence is

Animal-only or theoretical The physique rationale is nutrient partitioning: insulin drives glucose and amino acids into muscle, so administering it around training or around a large carbohydrate feed is supposed to fill glycogen faster and improve the anabolic response. It is usually described alongside growth hormone, on the reasoning that growth hormone raises glucose and insulin lowers it. At the top of the sport this is an open practice rather than a rumour.

The evidence for benefit in a healthy, well-fed, resistance-trained person is not weak — it is absent. There are no controlled trials of insulin for muscle gain or body composition in non-diabetic athletes, and there is no realistic prospect of one, because no ethics committee will approve deliberately inducing hypoglycaemia in healthy volunteers for a physique endpoint. What exists is mechanism, case series and the testimony of people with a reason to be believed and a reason not to be.

There is a specific reason to be sceptical of the mechanism as applied. In a person who is eating enough, training hard and already on supraphysiologic androgens, muscle protein synthesis is not obviously insulin-limited — the studies that separate insulin’s effect from amino acid availability generally find that insulin permits protein synthesis rather than driving it, and that ordinary post-meal levels are enough to saturate that permission. Much of the visible change people attribute to it is glycogen and the water that comes with glycogen, which is real, and is not the same thing as tissue.

Established clinical use What is not in doubt is that insulin promotes fat storage with the same enthusiasm it promotes glycogen storage. It does not select for the outcome anyone wants.

The failure mode

Established clinical use Hypoglycaemia is not a side effect of insulin in the way that nausea is a side effect of a GLP-1. It is the same action, taken further than intended. Every other compound on this site has a risk profile you would notice over weeks or months and could act on. This one has a risk that can begin within twenty minutes and be irreversible within an hour.

The sequence is consistent. Early: sweating, tremor, a racing heart, hunger, anxiety — the adrenaline response to a falling glucose. Then the brain runs short: confusion, slurred speech, poor judgement, an inability to recognise what is happening or to do the simple thing that would fix it. Then seizure, then coma. The critical feature is that the stage where a person could still save themselves ends before the danger does. Once someone is unconscious, they cannot eat, and there is nothing about insulin that wears off fast enough to matter.

That is why sleep is the recurring circumstance in the case reports. So is being alone. Hypoglycaemic deaths and permanent hypoglycaemic brain injury in bodybuilders are documented in the medical literature, and the accounts share a pattern: a dose taken, a meal that did not follow, and no one present. Prolonged neuroglycopenia does not always kill — sometimes it leaves someone alive with a brain that no longer works properly, which is the outcome that rarely gets discussed.

Established clinical use There is a second, quieter failure mode. Insulin drives potassium into cells along with glucose, and a large dose can drop serum potassium enough to cause arrhythmia. It is the reason hospitals give insulin deliberately to treat hyperkalaemia. It is invisible without a blood test, and it does not announce itself the way a hypo does.

The margin also moves, which is the part that catches experienced users rather than new ones. Alcohol suppresses the liver’s ability to release stored glucose, so the same dose goes further after drinking. Unplanned cardio, a hot shower, a sauna, heat, a missed or delayed meal, a smaller meal than expected, an injection into a site about to be exercised — each of these deepens the same drop. A dose that was fine ten times is not thereby a safe dose.

Why there is no dose on this page, and what to know if it is in your protocol anyway

Every compound page on this site strips performance dosing, and this is the one where that policy needs no defending. Prescribed insulin is titrated by a clinician against measured glucose: an estimate from body weight and current control, then weeks of adjustment against readings. The dose is an output of measurement. There is no table it can be read off, and a number published here would be a number applied by someone whose circumstances it was never derived from.

If insulin is in your protocol for any reason, medical or not, the boring part is the entire safety system. Glucose measured before and after each dose and again before sleep; a continuous glucose monitor if you can get one, because it is the only monitoring that works while you are asleep and it alarms before you would notice. Fast-acting carbohydrate within arm’s reach every single time — glucose tablets, juice, regular soda, not something that needs cooking. Someone nearby who knows what you have taken and what a hypo looks like, because the person having one is the person least able to describe it. Glucagon, as a nasal powder or an auto-injector, is what that person uses when you can no longer swallow, and it is available on prescription. If someone is confused or unresponsive: emergency services first, glucagon if it is there, nothing by mouth into an unconscious person.

Established clinical use Two more things worth knowing plainly. Insulin syringes are marked in units rather than millilitres, and pens deliver in units too — unit-versus-millilitre confusion and pen-versus-syringe confusion are documented sources of tenfold overdose in hospitals, where people do this professionally. And in the United States, regular human insulin is sold without a prescription in most states, which makes the most dangerous compound in this reference also one of the easiest to obtain. Cheap and available are facts about supply chains, not about safety.

The honest summary is that insulin has an unmatched record as replacement therapy for people who cannot make their own, and no controlled evidence at all as a physique drug, set against a failure mode that is fast, common in the case reports, and unforgiving of an ordinary bad day. That is a real trade-off and it belongs to the person making it, but it should be made with a doctor who knows what else you are taking rather than from a forum thread.

The dosing rows the app records

Established clinical use Reproduced from the app’s reference so you can see what it holds, not as a recommendation. Which row applies to a particular person, if any, is a clinical decision this page does not make — and rows describing supraphysiological or post-cycle use are filtered out before this table is built, so what you see here is a subset.

What the app monitors alongside it

The panel below is the app’s own monitoring note for Insulin, verbatim. The analytes in it that have a page here are linked; those pages cover what each one measures, which assay produced it and how to read a trend.

• Hematocrit on testosterone therapy
• HbA1c and fasting glucose

Drawbacks and risks the app records

From the app’s own entry. The first two items are the page: everything else is a consequence of them.

• Hypoglycaemia is the failure mode and it can be fatal within an hour
• No self-rescue once consciousness is lost — someone else has to act
• No controlled evidence of performance or body-composition benefit in non-diabetics
• Deaths and permanent brain injury in bodybuilders are documented in case reports
• The margin narrows with a missed meal, alcohol, heat, cardio or a hot shower
• Drives potassium into cells — hypokalaemia is a second, quieter failure mode
• Promotes fat storage as readily as glycogen storage
• Sustained high exposure is associated with worsening insulin resistance

Interaction rules that name Insulin

From the app’s interaction data, filtered so no rule naming a compound this site does not publish appears. Not exhaustive, and not a safety clearance: a combination that is not listed is one nobody has documented here, which is not the same as one that is fine. The combination checker has the rest.

Questions people actually ask

Is insulin legal to buy?

In the United States, regular human insulin — Humulin R and Novolin R — is sold without a prescription in most states. The rapid- and long-acting analogues require one. Being legal and being safe are unrelated questions here, and the availability is a large part of why the risk is worth spelling out.

Does it actually build muscle?

There are no controlled trials in non-diabetic athletes, and there are unlikely ever to be, because inducing hypoglycaemia in healthy volunteers for a physique endpoint is not approvable. The mechanistic case is that insulin permits protein synthesis rather than driving it, and that ordinary post-meal levels already saturate that. Much of the visible effect is glycogen and water.

What does a hypo feel like?

Sweating, shaking, a racing heart, sudden hunger and anxiety first. Then confusion, slurred speech and impaired judgement as the brain runs short of glucose — and that stage is the problem, because it removes the ability to recognise what is happening and act on it. Seizure and coma follow.

What do you do if someone is confused or unresponsive?

If they can still swallow reliably, fast-acting carbohydrate: glucose tablets, juice, regular soda. If they cannot, call emergency services and give glucagon if it is available — nasal or auto-injector. Never put anything in the mouth of an unconscious person.

Why does this page carry no dose?

Because insulin dosing is titrated against measured glucose by someone who can see the whole picture, not chosen from a reference table. Every compound page here strips performance dosing; this is the one where publishing a number could kill a reader.

Does it interact with semaglutide or tirzepatide?

Yes, and it is a recognised clinical interaction rather than a theoretical one. GLP-1 agonists lower glucose and suppress appetite, so the same insulin dose goes further. Guidelines call for the insulin to be reduced when a GLP-1 is started or increased, under medical supervision.

Where the load-bearing numbers come from

Named rather than linked. Publisher URLs move, and a citation that resolves to a 404 two years from now is worse than one you can search for by name — every entry below is findable from the title and year alone.